logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Osmotic Laxative class drugs

    FiltersReset Filters
    8 results
    • arimidex

      (Anastrozole)
      ANI Pharmaceuticals, Inc.
      Usage: ARIMIDEX is indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatment of hormone receptor-positive or unknown locally advanced and metastatic breast cancer, particularly after disease progression on tamoxifen therapy.
    • lactulose

      (Lactulose)
      Chartwell RX, LLC
      Usage: This drug is indicated for treating constipation, particularly in patients with chronic constipation. It increases both the frequency of bowel movements per day and the number of days bowel movements occur.
    • lactulose

      (Lactulose)
      Chartwell RX, LLC.
      Usage: Lactulose is indicated for treating constipation, particularly in patients with a history of chronic constipation. It increases the frequency of bowel movements and the number of days patients experience bowel activity.
    • lactulose

      (Lactulose)
      APOZEAL PHARMACEUTICALS INC
      Usage: Lactulose is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma stages. It reduces blood ammonia levels, improves mental state and EEG patterns, and enhances protein tolerance. Clinical response is observed in about 75% of patients, comparable to neomycin therapy.
    • lactulose

      (Lactulose)
      APOZEAL PHARMACEUTICALS INC
      Usage: Lactulose solution is indicated for the treatment of constipation, particularly in patients with chronic constipation. It enhances the frequency of bowel movements and increases the number of days with bowel movements.
    • lactulose

      (Lactulose)
      Foxland Pharmaceuticals, Inc.
      Usage: Lactulose is indicated for the treatment of constipation, particularly in patients with chronic constipation, by increasing the frequency of bowel movements and the number of days on which they occur.
    • lactulose solution

      (Lactulose Solution USP, 10 g/15 mL)
      Rising Pharmaceuticals, Inc.
      Usage: Lactulose is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels, improves mental state, and enhances EEG patterns, with a positive clinical response in about 75% of patients, often increasing protein tolerance.
    • moviprep

      (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE)
      Salix Pharmaceuticals, Inc.
      Usage: MoviPrep® is an osmotic laxative indicated for colonic cleansing prior to colonoscopy in adults.